Breaking News, Financial News

Financial Report: Patheon 1Q11

Commercial manufacturing revenues were up 16% to $148.7 million

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 1Q11

1Q Revenues: $175.7 million (+12%)

1Q Loss: $500,000 (loss of $11.1 million 1Q10)

Comments: Commercial manufacturing revenues were up 16% to $148.7 million. North American commercial revenues were $5.1 million (+9%). European commercial revenues were $15.5 million (+22%). Pharmaceutical Development Services revenues were $27.0 million (+1%). European commercial revenues benefited from a $30 million reservation payout by a client that chose not to continue a lyophilized cephalosporin project after receiving a complete response letter.


Click here to learn more about Patheon

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters